1- , dewanggay369@gmail.com
2- Medical Faculty, Brawijaya University, Malang, Indonesia
3- Oncology Surgery Department, Universitas Airlangga Hospital, Faculty of Medicine, Airlangga University, Surabaya, Indonesia
4- Oncology Surgery Department, Paru Hospital, Jember University, Jember, Indonesia
Abstract: (25 Views)
Background: Postoperative pain remains common after surgery, and opioid-related adverse effects motivate multimodal alternatives. The serratus plane block (SPB) is used for breast surgery, but its comparative benefit remains uncertain.
Methods: We searched PubMed, the Cochrane Library, and ProQuest for English-language randomized trials and cohort studies published between January 2019 and December 2024 comparing an SPB-related intervention with a control or another technique in breast cancer surgery. We used RoB 2 and ROBINS-I to assess risk of bias. Random-effects analyses assessed pain at postoperative time points; secondary outcomes included rescue analgesia, postoperative nausea and vomiting (PONV), and operative duration.
Results: Eight studies (834 participants) were included. Bias concerns were generally low to moderate, with concerns about blinding and cohort confounding. SPB usually favored lower time-specific pain, but heterogeneity was often very high, and some comparisons were not significant. Rescue analgesia was less likely (OR 0.25, 95% CI 0.08–0.72; P=0.01; I²=66%) and PONV risk was lower (RR 0.31, 95% CI 0.12–0.80; P=0.02; I²=53%). Operative duration did not differ significantly (MD −3.69 min, 95% CI −7.52 to 0.14; P=0.06; I²=7%).
Conclusion: SPB may be considered as part of individualized multimodal analgesia, but heterogeneous protocols and limited evidence do not support universal superiority or routine use as standard of care.
Type of Study:
review |
Subject:
Diagnosis, treatment, rehabilitation Received: 2026/07/25 | Accepted: 2026/09/30